IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
608.41
-10.51 (-1.70%)
At close: Mar 6, 2026, 4:00 PM EST
606.48
-1.93 (-0.32%)
After-hours: Mar 6, 2026, 6:29 PM EST
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 715, with a low estimate of 475 and a high estimate of 805. The average target predicts an increase of 17.52% from the current stock price of 608.41.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 5 | 5 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $775 → $750 | Hold | Maintains | $775 → $750 | +23.27% | Feb 9, 2026 |
| Barclays | Barclays | Buy Maintains $850 → $800 | Buy | Maintains | $850 → $800 | +31.49% | Feb 5, 2026 |
| UBS | UBS | Hold Maintains $750 → $730 | Hold | Maintains | $750 → $730 | +19.98% | Feb 3, 2026 |
| BTIG | BTIG | Strong Buy Maintains $830 → $800 | Strong Buy | Maintains | $830 → $800 | +31.49% | Feb 3, 2026 |
| Barclays | Barclays | Buy Initiates $850 | Buy | Initiates | $850 | +39.71% | Dec 9, 2025 |
Financial Forecast
Revenue This Year
4.77B
from 4.30B
Increased by 10.83%
Revenue Next Year
5.18B
from 4.77B
Increased by 8.60%
EPS This Year
14.82
from 13.08
Increased by 13.33%
EPS Next Year
16.71
from 14.82
Increased by 12.69%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.9B | 5.4B | |||
| Avg | 4.8B | 5.2B | |||
| Low | 4.5B | 4.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.8% | 13.9% | |||
| Avg | 10.8% | 8.6% | |||
| Low | 5.6% | 2.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.47 | 17.73 | |||
| Avg | 14.82 | 16.71 | |||
| Low | 14.03 | 15.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.2% | 19.6% | |||
| Avg | 13.3% | 12.7% | |||
| Low | 7.3% | 3.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.